🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Microvascular Angina

Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease NCT02301663NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: Handgrip, Altitude simulation, Leg exercise Barts-MINOCA Registry NCT04440761n/a1 site📍 London Queen Mary University of London · Tests: Observation only Evaluation of the Efficacy of MACitentan in the Treatment of CoronaryMICrovascular Angina (MACMIC) NCT06811831EARLY Phase 11 site📍 Beijing China-Japan Friendship Hospital · Tests: Macitentan 10 mg tablet, once daily. Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) NCT06092736Phase 41 site📍 Jinan Qilu Hospital of Shandong University · Tests: Compound Danshen Dropping Pills, Placebo Non-invasive Diagnosis of Coronary Microvascular Disease: Pilot Study NCT06070662n/a1 site📍 Leicester University of Leicester · Tests: Coronary microvascular disease testing during coronary angiography, Cardiac magnetic resonance scan including exercise,… Comprehensive Coronary Physiology in Patients With Angina With Nonobstructive Coronary Arteries - Czech Republic NCT07103317n/a1 site📍 Prague University Hospital, Motol Coronary Microvascular Disease (CMD) Registry NCT05960474n/a3 sites📍 Washington D.C.📍 Hollywood📍 Clinton Medstar Health Research Institute · Tests: Outcomes for Patients with CMD COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina NCT04606459NA1 site📍 Mainz Johannes Gutenberg University Mainz · Tests: Coronary sinus reducer, Optimal medical therapy Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correlation With Metabolic Syndrome and Insulin-Secreting Cells. NCT06801769NA2 sites📍 Rome📍 Rome Catholic University of the Sacred Heart · Tests: C-peptide Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG) NCT06600178Phase 11 site📍 Charlottesville University of Virginia · Tests: Brenzavvy (bexagliflozin), 20 mg Oral Tablet, Placebo Mental Stress Reactivity in Women With CMD NCT05401630NA4 sites📍 Atlanta📍 Atlanta📍 Atlanta Emory University · Tests: Study Procedures The Early Warning System for the Diabetic Encephalopathy NCT02420470n/a1 site📍 Xi'an Tang-Du Hospital iCorMicA - Stratified Medicine in Angina NCT04674449NA39 sites📍 Cork📍 Dublin📍 Nijmegen NHS Greater Glasgow and Clyde · Tests: Disclosure of IDP results, IDP performed but results not disclosed Impact of Hyperemic State on Angio-IMR Performance NCT07613996n/a2 sites📍 Shanghai📍 Guangzhou Shanghai Zhongshan Hospital · Tests: Angiography-derived IMR Myocardial Ischemia Without Obstructive Coronary Stenoses NCT04827498n/a1 site📍 Madrid Hospital San Carlos, Madrid · Tests: Invasive coronary endothelium-dependent and non-endothelium-dependent physiological assessment Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP) NCT06650943NA1 site📍 Bilbao Hospital de Basurto · Tests: Nursing Consultation in Weight Management and Metabolic syndrome Sex Difference of Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease NCT06076551n/a1 site📍 Seoul Korea University Anam Hospital · Tests: Adenosine stress echocardiography Identification of a Score for the Assessment of Intrapancreatic Fat NCT07155473NA1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: C-peptide dosage Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries NCT06424834Phase 2, Phase 31 site📍 Palo Alto Stanford University · Tests: Amlodipine, Nebivolol, Placebo Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition NCT06125392n/a1 site📍 Mainz Johannes Gutenberg University Mainz · Tests: Coronary physiology assessment Lower Silesia Sinus Reducer Registry NCT06288165n/a2 sites📍 Lubin📍 Lubin Miedziowe Centrum Zdrowia SA · Tests: Coronary Sinus Reducer Implantation Imaging Coronary Microvascular Dysfunction (CMD) Study NCT05634031NA1 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: PET imaging, Coronary CT angiogram, Functional Angiography, Treadmill exercise stress study The Value of Measuring Retinal Vascular Density by Optical Coherence Tomography-Angiography (OCT-A) in Patients With Microvascular Angina Confirmed by Myocardial Microcirculatory Resistance Index (MRI). NCT06692751n/a1 site📍 Dijon Centre Hospitalier Universitaire Dijon · Tests: Blood sampling, Ophthalmological examination, angina severity questionnaire Southeastern Europe Microcirculation Registry NCT06393478n/a10 sites📍 Rijeka📍 Zagreb📍 Athens Institute for Cardiovascular Diseases Dedinje Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry NCT03479580n/a1 site📍 La Tronche University Hospital, Grenoble · Tests: Patients with a cardiomyopathy Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA NCT06864234Phase 41 site📍 Aalst VZW Cardiovascular Research Center Aalst · Tests: Saline (NaCl), Metoprolol Tartrate Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective, Multicenter, Single-Group Target Value Study NCT07453381n/a5 sites📍 Beijing📍 Cangzhou📍 Chengdu Peking University Third Hospital Qishenyiqi Dripping Pill for Coronary Microvascular Disease NCT06699420Phase 43 sites📍 Jinan📍 Jinan📍 Jinan Qilu Hospital of Shandong University · Tests: Qishenyiqi dripping pills 1 bag, three times a day, Placebo 1 bag, three times a day Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function in Patients With Heart Failure With Reduced Ejection Fraction Caused by Non-ischemic Etiology NCT06243653n/a1 site📍 Seoul Samsung Medical Center · Tests: CMD test The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease NCT06606821Phase 43 sites📍 Copenhagen📍 Gentofte Municipality📍 Herlev Tina Vilsbøll · Tests: Tirzepatide, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy